Spectral Capital (OTC: FCCN) just quietly released their February 2026 investor presentation….. and honestly?

It doesn't read like your typical micro-cap pitch.

It reads like an infrastructure thesis.

They're building the full stack:

  • A quantum-resistant Layer 1 blockchain designed for AI agent orchestration

  • A decentralized hardware network underneath it

  • ANDDDDDD 48 patents across quantum computing, AI, and blockchain tying the whole thing together.

They've already completed two acquisitions, FortyTwo (quantum + AI R&D) and Telvantis (telecom infrastructure) with more in the pipeline. And their roadmap puts a $450M+ pro forma revenue goal on the table.

Click here to learn more about what they’re building.

Meta and Nvidia just made it official. This deal includes the whole stack. AMD dropped 4% on the news the same day.

Netflix just let its rival back into the room. The decision involves Warner Bros. Discovery and Paramount's "best and final" offer. Netflix is watching.

A federal agency ran out of money while Congress was on vacation.
It hit a funding deadline, lawmakers were out of town. Timing is everything.

TODAY'S POLYMARKET POLL

Congress Keeps Almost Banning Itself From Trading Stocks— Almost

In 2025, members of Congress made over 13,000 stock trades.

Combined, they pocketed an estimated $635 million.

And 29 of them beat the S&P 500. Split almost perfectly down the middle between Democrats and Republicans.

That last part is worth sitting with.

The S&P had a solid year.
Most professional fund managers didn't beat it.

But people who spend their days writing the rules that govern entire industries, managed to outperform one of the hardest benchmarks in finance.

Repeatedly.

What Actually Happened

CNN's investigation found something that would be embarrassing if shame still existed in Washington:

At least 10 senators made trades in companies directly tied to the committees they sit on.

We're talking about a senator buying Alphabet stock the same day he participates in an AI regulation hearing.

A senator investing in a cybersecurity firm whose government contracts his committee directly oversees.

Another selling medical device stock in a company that was actively lobbying his health committee one month prior.

Each of them, when asked, said the same thing:

I don't personally make the trades. It's a broker. I had no idea.

The trades still happened. The profits still landed.

And the committees still make decisions that move those stocks.

The Ban That Keeps Not Happening

Here's where it gets structural.

There is genuine bipartisan support for a ban. 86% of Americans want one.

And the Restore Trust in Congress Act had 127 co-sponsors from both sides of the aisle.

It's been killed anyway.

Twice, in two different ways.

First, Democratic House Minority Leader Hakeem Jeffries introduced a separate bill that added Trump and Vance to the scope — a political poison pill dressed up as principle.

Ethics advocates called it out immediately:

It wasn't designed to pass, it was designed to tank the bill that could.

Then Speaker Mike Johnson stepped in with a "compromise" so hollow that watchdog groups called it a paper tiger.

Members could keep all their current holdings.
They just need to give seven days notice before selling.

That's it. A week's heads-up, on trades they already claim not to control.

The House Administration Committee passed it along party lines.

Why This Is a Market Problem, Not Just a Political One

When the people writing industry regulations are also holding positions in those industries, the market is not playing on a level field.

Information about upcoming regulation, contract awards, or policy shifts is exactly the kind of edge that would get anyone else investigated by the SEC.

The current system doesn't just tolerate this.

It is built around it.

The 2012 STOCK Act was supposed to fix disclosure.

But it didn't fix the conflict. It just made the conflict visible.

And every attempt to fix the actual problem gets quietly dismantled before it reaches a vote.

That's not dysfunction.

That's the system working exactly as the people running it prefer.

How’s the stock market today?

Amazon Lost $450 Billion in 9 Days — Then Bill Ackman Bought More

Amazon just had its worst losing streak since 2006.

9 straight days of red.

The stock dropped 18%, wiping out roughly $450 billion in market cap, and landing around $199 per share.

The reason?

Amazon told Wall Street it plans to spend $200 billion on AI infrastructure this year.

Wall Street did not take it well.

What Spooked Investors

Capital expenditure at that scale makes analysts nervous, and understandably so.

$200 billion is not a rounding error.

It's a structural commitment that compresses margins in the near term with no guaranteed payoff date attached.

After years of riding high on AWS growth and advertising revenue, the market wanted efficiency.

Amazon handed them a construction bill instead.

So investors sold. Hard. For nine consecutive sessions.

Then Something Else Happened

While the selloff was still unfolding, Bill Ackman's Pershing Square quietly grew its Amazon position by 65% in Q4.

It's now a $1.16 billion stake — his third-largest holding.

Ackman didn't make a public case for it.

No tweets, no investor letters calling the dip a generational opportunity.

The position just showed up in the filings, as it does when someone buys without needing an audience.

Make of that what you will.

What the Analysts Say — And What History Says

41 out of 44 Wall Street analysts still rate Amazon a Buy.

Their average price target sits at $282, which would represent about 43% upside from where the stock is now.

That's not a fringe view.
That's near-unanimous conviction from people paid to be right about this.

Then there's 2006.

The last time Amazon strung together a losing streak this long, the stock went on to gain 128% the following year.

That's one data point.

Not a guarantee, not a pattern, and the situations aren't identical.

But it's the kind of number that tends to make people stop scrolling.

The Actual Question

The market's frustration with Amazon isn't really about $200 billion.

It's about timing. Investors who bought at highs want returns now, not in three years when the AI infrastructure starts compounding.

Amazon is essentially telling shareholders:

Trust the long game.

Whether that's visionary capital allocation or an expensive bet on infrastructure that may or may not pay off?

Nobody actually knows yet.

What's clear is that the selloff happened, a significant amount of smart money moved in during it, and the analyst consensus barely flinched.

Something to keep an eye on.

WINNERS & LOSERS LAST 7 DAYS

(NCI) Neo-Concept International...

+283.33%

(RXT) Rackspace Technology, Inc.

+225.74%

(RIME) Algorhythm Holdings, Inc.

+206.90%

(SNSE) Sensei Biotherapeutics, Inc.

+203.86%

(MLEC) Moolec Science SA

+199.80%

(POAS) Phaos Technology Holdin…

-83.87%

(AREB) American Rebel Holdings…

-83.09%

(SSKN) STRATA Skin Sciences, Inc.

-82.94%

(LIMN) Liminatus Pharma, Inc.

-78.62%

(JDZG) JIADE Limited

-78.29%

Keep Reading